Fortress Biotech
FBIO
54 hedge funds and large institutions have $28.8M invested in Fortress Biotech in 2017 Q2 according to their latest regulatory filings, with 10 funds opening new positions, 12 increasing their positions, 17 reducing their positions, and 4 closing their positions.
150% more first-time investments, than exits
New positions opened: 10 | Existing positions closed: 4
20% more capital invested
Capital invested by funds: $24M → $28.8M (+$4.8M)
13% more funds holding
Funds holding: 48 → 54 (+6)
0.06% less ownership
Funds ownership: 0.86% → 0.8% (-0.06%)
29% less repeat investments, than reductions
Existing positions increased: 12 | Existing positions reduced: 17
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AHB
Abner Herrman & Brock
Jersey City,
New Jersey
|
+$409K |
| 2 |
BlackRock
New York
|
+$385K |
| 3 |
State Street
Boston,
Massachusetts
|
+$237K |
| 4 |
Renaissance Technologies
New York
|
+$168K |
| 5 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
+$163K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
ACA
Avoro Capital Advisors
New York
|
-$1.55M |
| 2 |
Millennium Management
New York
|
-$739K |
| 3 |
Vanguard Group
Malvern,
Pennsylvania
|
-$419K |
| 4 |
VKH
Virtu KCG Holdings
New York
|
-$188K |
| 5 |
CAM
ClariVest Asset Management
San Diego,
California
|
-$168K |
FBIO Hedge Fund Activity: Q2 2017 in Review
54 of the 4,011 institutional investors tracked by Wall St. Rank reported a position in Fortress Biotech (FBIO) for Q2 2017, worth a combined $28.8M — up 20% from $24M a quarter earlier.
Buyers outnumbered sellers: 10 funds opened new FBIO positions and 4 closed out — a net gain of 6 holders — while 12 added to existing stakes and 17 trimmed.
The largest buyer was Abner Herrman & Brock, opening a new position worth an estimated $409K. The largest seller was Avoro Capital Advisors, cutting an estimated $1.55M.
- 54 institutional investors held Fortress Biotech (FBIO) as of Q2 2017, up from 48 in Q1 2017.
- Funds reported $28.8M of Fortress Biotech stock for Q2 2017, up 20% quarter-over-quarter.
- 10 funds opened new Fortress Biotech positions in Q2 2017 and 4 closed out, a net change of +6 holders.
- The largest Fortress Biotech buyer in Q2 2017 was Abner Herrman & Brock, an estimated $409K added.
- The largest Fortress Biotech seller in Q2 2017 was Avoro Capital Advisors, an estimated $1.55M sold.
Based on aggregated 13F filings for Q2 2017.